Oncozenge (ONCOZ.ST) Stock Price
Oncozenge Price
Over the last 2 years Oncozenge grew revenue by 2,879.9% annually, reaching 2.66 M SEK. For Oncozenge, the net margin of -598.3% is up versus -530,066.7% a few years ago.
Oncozenge stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Oncozenge business model & stock analysis
Frequently asked questions about Oncozenge
Converted at the current exchange rate, the Oncozenge share trades at 0.30 EUR (3.35 SEK).
The Oncozenge share (ONCOZ.ST) is listed on 3 stock exchanges, including: Frankfurt (8LY.F), Stockholm (ONCOZ.ST).
The expected revenue of Oncozenge is 5.80 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Oncozenge is -10.55 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Oncozenge is currently -4.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Oncozenge stock.
The price-to-sales ratio (P/S) of Oncozenge is currently 7.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Oncozenge stock.
The Eulerpool Quality Score for Oncozenge is 3/10.
The ISIN of Oncozenge is SE0015504097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Oncozenge is A2QNQR. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Oncozenge is ONCOZ.ST. The ticker symbol is used to trade Oncozenge shares on the stock exchange.
Oncozenge stock
Oncozenge Peer Group
Oncozenge Ticker
Oncozenge FIGI
All fundamentals and in-depth analysis of Oncozenge
Our stock analysis for Oncozenge stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncozenge. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.